Target- |
Mechanism- |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
HC001 颗粒治疗小儿急性水样腹泻(湿热证)探索其有效性及安全性的随机、双盲、极低剂量平行对照、多中心Ⅱ期临床研究
[Translation] A randomized, double-blind, very low-dose parallel-controlled, multicenter phase II clinical study to explore the efficacy and safety of HC001 granules in the treatment of acute watery diarrhea (damp-heat syndrome) in children
1、评价 HC001 颗粒治疗小儿急性水样腹泻(湿热证),改善腹泻症状和缩短腹泻病程的作用。
2、观察 HC001 颗粒临床应用的安全性。
[Translation] 1. Evaluate the effect of HC001 granules in treating acute watery diarrhea (damp-heat syndrome) in children, improving diarrhea symptoms and shortening the course of diarrhea.
2. Observe the safety of HC001 granules in clinical application.
100 Clinical Results associated with Beijing Houcheng Medical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Houcheng Medical Technology Co., Ltd.
100 Deals associated with Beijing Houcheng Medical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Houcheng Medical Technology Co., Ltd.